Ara
Toplam kayıt 16, listelenen: 1-10
Status of the epicardial coronary arteries in non-ST elevation acute coronary syndrome in patients with mechanical prosthetic heart valves (from the TROIA-ACS Trial)
(Elsevier Inc., 2018)
Coronary thromboembolism (CE) is a rare cause of prosthetic valve derived complications. This study investigates the diagnosis and treatment strategies for non-ST elevation acute coronary syndrome (NSTEACS) in patients ...
Complementary role of cardiac computed tomography to transesophageal echocardiography in the evaluation of prosthetic valve dysfunction
(Elsevier Ireland Ltd, 2017)
Dear Editor,
We have read with great interest the article by Suh et al. describingtheadded value of cardiaccomputed tomography(CT) in theevaluationof pannus overgrowth on mechanical prosthetic valves[1]. Cardiac CThas a ...
The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis
(Elsevier Ltd, 2018)
Introduction: Procoagulant activity of heparanase has been recently described in several arterial and venous thrombotic disorders. In this study, we aimed to investigate the role of heparanase with regard to thrombus burden, ...
The role of protein Z and protein Z-dependent protease ınhibitor polymorphisms in the development of prosthetic heart valve thrombosis
(2017)
BACKGROUND AND AIM OF THE STUDY: Protein Z (PZ) is a vitamin K-dependent factor that is synthesized mainly by the liver. It acts as an activator of serpin, the protein Z-dependent inhibitor (ZPI), which inhibits factor Xa. ...
How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis
(Springer New York LLC, 2018)
Over the last two decades, thrombolytic therapy (TT) has become an alternative to surgery as a first-line therapy in patients with thrombosed mechanical valves [1, 2, 3]. In TROIA Trial, low dose (25 mg)—slow infusion (6 ...
What is the importance of real-time three dimensional transesophageal echocardiography and time in therapeutic range in patients with prosthetic valve thrombosis?
(Springer New York LLC, 2018)
We have recently read with great interest the article reported by Cınar et al. which was published in the last issue of the Journal of Thrombosis and Thrombolysis [1]. We appreciate the authors for their report describing ...
Evaluation of the potential predictors of embolism in patients with left atrial myxoma
(Blackwell Publishing Inc., 2019)
Introduction: Cardiac myxomas are the most common primary intracardiac tumors. Although myxomas are histologically benign, they are potentially dangerous due to potential risk of systemic and cerebral embolism. In this ...
Comparison of different anticoagulation regimens in pregnant patients with mechanical prosthetic heart valves
(Oxford Univ Press, 2017)
[Abstract Not Available]
Comparison of Different Anticoagulation Regimens Regarding Maternal and Fetal Outcomes in Pregnant Patients With Mechanical Prosthetic Heart Valves (from the Multicenter ANATOLIA-PREG Registry)
(Excerpta Medica Inc-Elsevier Science Inc, 2020)
Mechanical prosthetic heart valves (MPHVs) are highly thrombogenic, and a pregnancyinduced procoagulant status increases the risk of MPHV thrombosis. Despite numerous case reports, 2 major registries and meta-analyses/systematic ...
Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations
(Taylor & Francis Ltd, 2020)
Introduction: Prosthetic heart valve thrombosis is a life-threatening complication after valve replacement surgery. Although subtherapeutic anticoagulation is the main cause, there are many other conventional and esoteric ...